Caroen相关文献与解析，生知库 | 链接生命科学的每一步

BETA prime: a first-in-man phase 1 study of AdAPT-001, an armed oncolytic adenovirus for solid tumors

BETA prime：AdAPT-001（一种用于治疗实体瘤的武装溶瘤腺病毒）的首次人体I期研究

Conley, Anthony P; Roland, Christina L; Bessudo, Alberto; Gastman, Brian R; Villaflor, Victoria M; Larson, Christopher; Reid, Tony R; Caroen, Scott; Oronsky, Bryan; Stirn, Meaghan; Williams, Jeannie; Burbano, Erica; Coyle, Angelique; Barve, Minal A; Wagle, Naveed; Abrouk, Nacer; Kesari, Santosh

微生物学

发表日期：2024

文献求助收藏

Molecular Mechanisms of Nemorosone-Induced Ferroptosis in Cancer Cells

奈莫罗酮诱导癌细胞铁死亡的分子机制

期刊:Cells

影响因子:5.1

doi:10.3390/cells12050735

Roberto Fernández-Acosta, Behrouz Hassannia, Jurgen Caroen, Bartosz Wiernicki, Daniel Alvarez-Alminaque, Bruno Verstraeten, Johan Van der Eycken, Peter Vandenabeele, Tom Vanden Berghe, Gilberto L Pardo-Andreu

THU582 Actionable Circulating Proteins Mediate The Effect Of Obesity On Cardiometabolic Diseases: An Integrative Proteogenomics Analysis

THU582 可操作循环蛋白介导肥胖对心血管代谢疾病的影响：一项整合蛋白质组学分析

期刊:Cancers

影响因子:4.4

doi:10.3390/cancers14194701

Oronsky, Bryan; Gastman, Brian; Conley, Anthony P; Reid, Christopher; Caroen, Scott; Reid, Tony; Yoshiji, Satoshi; Lu, Tianyuan; Butler-Laporte, Guillaume; Carrasco-Zanini-Sanchez, Julia; Chen, Yiheng; Liang, Kevin; Sunday Willett, Julian Daniel; Su, Chen-Yang; Wang, Shidong; Adra, Darin; Ilbudo, Yann; Takayoshi, Sasako; Forgetta, Vincenzo; Farjoun, Yossi; Zeberg, Hugo; Zhou, Sirui; Machiela, Mitchell; Hultstrom, Michael; Wareham, Nicholas; Timpson, Nicholas J; Mooser, Vincent; Langenberg, Claudia; Richards, Brent

RRx-001: a chimeric triple action NLRP3 inhibitor, Nrf2 inducer, and nitric oxide superagonist

RRx-001：一种嵌合型三效 NLRP3 抑制剂、Nrf2 诱导剂和一氧化氮超激动剂

期刊:Frontiers in Oncology

影响因子:3.3

doi:10.3389/fonc.2023.1204143

Oronsky, Bryan; Takahashi, Lori; Gordon, Richard; Cabrales, Pedro; Caroen, Scott; Reid, Tony

A multicenter, phase 1, dose escalation clinical trial (G-FORCE-1) of XRT, RRx-001 and temozolomide followed by temozolomide +/- RRx-001 in newly diagnosed glioblastoma

一项多中心、I期、剂量递增临床试验（G-FORCE-1）研究了XRT、RRx-001和替莫唑胺联合治疗，随后进行替莫唑胺+/- RRx-001治疗，用于治疗新诊断的胶质母细胞瘤。

期刊:Frontiers in Oncology

影响因子:3.3

doi:10.3389/fonc.2023.1176448

Fine, Howard; Reid, Tony; Caroen, Scott; Oronsky, Bryan; Abrouk, Nacer; Butowski, Nicholas

细胞生物学

发表日期：2023

文献求助收藏

Data Management 101 for drug developers: A peek behind the curtain

药物研发人员数据管理入门：揭秘幕后故事

期刊:Cts-Clinical and Translational Science

影响因子:2.8

doi:10.1111/cts.13582

Oronsky, Bryan; Burbano, Erica; Stirn, Meaghan; Brechlin, Joanne; Abrouk, Nacer; Caroen, Scott; Coyle, Angelique; Williams, Jeannie; Cabrales, Pedro; Reid, Tony R

发表日期：2023

文献求助收藏

Hypothesis: AdAPT-001 and pseudoprogression - when seeing is not necessarily believing

假设：AdAPT-001 与假性进展——眼见不一定为实

TGF-β trap of AdAPT-001 turns up the heat on tumors and turns down checkpoint blocker resistance

AdAPT-001 的 TGF-β 陷阱可增强肿瘤的增殖活性并降低免疫检查点抑制剂的耐药性。

Lost at SCLC: a review of potential platinum sensitizers

小细胞肺癌治疗的困境：潜在铂类增敏剂的综述

Predicting the Abscopal Phenomenon-Letter to the Editor

预测远隔现象——致编辑的信

BETA prime: a first-in-man phase 1 study of AdAPT-001, an armed oncolytic adenovirus for solid tumors

BETA prime：AdAPT-001（一种用于治疗实体瘤的武装溶瘤腺病毒）的首次人体I期研究

Molecular Mechanisms of Nemorosone-Induced Ferroptosis in Cancer Cells

奈莫罗酮诱导癌细胞铁死亡的分子机制

THU582 Actionable Circulating Proteins Mediate The Effect Of Obesity On Cardiometabolic Diseases: An Integrative Proteogenomics Analysis

THU582 可操作循环蛋白介导肥胖对心血管代谢疾病的影响：一项整合蛋白质组学分析

RRx-001: a chimeric triple action NLRP3 inhibitor, Nrf2 inducer, and nitric oxide superagonist

RRx-001：一种嵌合型三效 NLRP3 抑制剂、Nrf2 诱导剂和一氧化氮超激动剂

A multicenter, phase 1, dose escalation clinical trial (G-FORCE-1) of XRT, RRx-001 and temozolomide followed by temozolomide +/- RRx-001 in newly diagnosed glioblastoma

一项多中心、I期、剂量递增临床试验（G-FORCE-1）研究了XRT、RRx-001和替莫唑胺联合治疗，随后进行替莫唑胺+/- RRx-001治疗，用于治疗新诊断的胶质母细胞瘤。

Data Management 101 for drug developers: A peek behind the curtain

药物研发人员数据管理入门：揭秘幕后故事